NasdaqGS - Delayed Quote USD

Treace Medical Concepts, Inc. (TMCI)

5.74
-0.12
(-2.05%)
At close: May 30 at 4:00:00 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-25,748
-37,167
-34,575
-30,648
-17,193
Investing Cash Flow
29,723
35,375
-81,299
-76,518
-2,705
Financing Cash Flow
63
160
109,383
20,806
107,652
End Cash Position
13,372
11,350
12,982
19,473
105,833
Interest Paid Supplemental Data
4,867
4,955
5,167
4,398
3,900
Capital Expenditure
-11,209
-11,593
-11,458
-14,838
-2,705
Issuance of Capital Stock
--
0
107,527
0
107,610
Issuance of Debt
--
0
0
53,501
0
Repayment of Debt
--
0
0
-33,893
-1,788
Free Cash Flow
-36,957
-48,760
-46,033
-45,486
-19,898
12/31/2021 - 4/23/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SGHT Sight Sciences, Inc.
3.6900
+4.83%
 
CTKB Cytek Biosciences, Inc.
2.7700
+6.95%
 
OFIX Orthofix Medical Inc.
11.25
-0.27%
 
MED.SW Medartis Holding AG
78.40
-1.38%
 
ENOV Enovis Corporation
31.30
-2.34%
 
CVRX CVRx, Inc.
6.64
-2.43%
 
BVS Bioventus Inc.
6.48
-1.22%
 
LUNG Pulmonx Corporation
3.4000
+6.25%
 
RPID Rapid Micro Biosystems, Inc.
3.3300
-1.19%
 
SIBN SI-BONE, Inc.
18.90
-0.42%